These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 36999050)
21. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma. Zou X; Hu Z; Huang C; Chang J Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949 [TBL] [Abstract][Full Text] [Related]
22. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma. Li F; Ge D; Sun SL BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754 [TBL] [Abstract][Full Text] [Related]
23. Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores. Xie H; Zhang JF; Li Q Int J Gen Med; 2021; 14():8677-8688. PubMed ID: 34849011 [TBL] [Abstract][Full Text] [Related]
24. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K Front Immunol; 2022; 13():947802. PubMed ID: 36405735 [TBL] [Abstract][Full Text] [Related]
25. Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification. Gao C; Kong N; Zhang F; Tang T; Li J; Ding H; Sun Z; Wu L; Xu M BMC Med Genomics; 2022 Jan; 15(1):15. PubMed ID: 35093068 [TBL] [Abstract][Full Text] [Related]
26. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma. Li W; Liu S; Su S; Chen Y; Sun G PeerJ; 2021; 9():e10470. PubMed ID: 33510968 [TBL] [Abstract][Full Text] [Related]
27. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases. Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836 [TBL] [Abstract][Full Text] [Related]
28. Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma. Xu Z; Chen C Biomed Res Int; 2021; 2021():6663990. PubMed ID: 34036102 [TBL] [Abstract][Full Text] [Related]
29. Six CT83-related Genes-based Prognostic Signature for Lung Adenocarcinoma. Wang Y; Zhang G; Wang R Comb Chem High Throughput Screen; 2022; 25(9):1565-1575. PubMed ID: 34259140 [TBL] [Abstract][Full Text] [Related]
30. Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures. Lu F; Gao J; Hou Y; Cao K; Xia Y; Chen Z; Yu H; Chang L; Li W Front Oncol; 2022; 12():876360. PubMed ID: 35785179 [TBL] [Abstract][Full Text] [Related]
31. Identification of a Seven-lncRNA Immune Risk Signature and Construction of a Predictive Nomogram for Lung Adenocarcinoma. Jin D; Song Y; Chen Y; Zhang P Biomed Res Int; 2020; 2020():7929132. PubMed ID: 32596372 [TBL] [Abstract][Full Text] [Related]
32. Development and Validation of a Prognostic Model to Predict Overall Survival for Lung Adenocarcinoma: A Population-Based Study From the SEER Database and the Chinese Multicenter Lung Cancer Database. Wang Z; Hu F; Chang R; Yu X; Xu C; Liu Y; Wang R; Chen H; Liu S; Xia D; Chen Y; Ge X; Zhou T; Zhang S; Pang H; Fang X; Zhang Y; Li J; Hu K; Cai Y Technol Cancer Res Treat; 2022; 21():15330338221133222. PubMed ID: 36412085 [No Abstract] [Full Text] [Related]
33. Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma. Ren J; Wang A; Liu J; Yuan Q Bioengineered; 2021 Dec; 12(1):4331-4348. PubMed ID: 34338158 [TBL] [Abstract][Full Text] [Related]
34. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma. Hu J; Wang T; Chen Q Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848 [TBL] [Abstract][Full Text] [Related]
35. Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma. Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S Aging (Albany NY); 2021 Jul; 13(14):18701-18717. PubMed ID: 34285141 [TBL] [Abstract][Full Text] [Related]
36. A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma. Ma S; Zhu J; Wang M; Zhu J; Wang W; Xiong Y; Jiang R; Seetharamu N; Abrão FC; Puthamohan VM; Liu L; Jiang T Transl Lung Cancer Res; 2022 Oct; 11(10):2079-2093. PubMed ID: 36386454 [TBL] [Abstract][Full Text] [Related]
37. Construction of a Novel Prognostic Signature in Lung Adenocarcinoma Based on Necroptosis-Related lncRNAs. Diao X; Guo C; Li S Front Genet; 2022; 13():833362. PubMed ID: 35938013 [No Abstract] [Full Text] [Related]
39. Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma. Chen S; Duan H; Xie Y; Li X; Zhao Y Ann Transl Med; 2021 May; 9(10):872. PubMed ID: 34164506 [TBL] [Abstract][Full Text] [Related]
40. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma. Zhao J; Lin X; Zhuang J; He F Front Genet; 2021; 12():714697. PubMed ID: 34777460 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]